Loss ofBAP1expression is associated with an immunosuppressive microenvironment in uveal melanoma, with implications for immunotherapy development-Reference-Cited by-同舟云学术

Loss ofBAP1expression is associated with an immunosuppressive microenvironment in uveal melanoma, with implications for immunotherapy development

Published:2020-03-17 Issue:4 Volume:250 Page:420-439
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:J. Pathol.

Author:

Figueiredo Carlos R¹²^ORCID,Kalirai Helen¹^ORCID,Sacco Joseph J¹³,Azevedo Ricardo A⁴,Duckworth Andrew¹,Slupsky Joseph R¹^ORCID,Coulson Judy M⁵^ORCID,Coupland Sarah E¹⁶^ORCID

Affiliation:

1. Department of Molecular and Clinical Cancer Medicine, ITM University of Liverpool Liverpool UK

2. Department of the Faculty of Medicine, MediCity Research Laboratory and Institute of Biomedicine University of Turku Turku Finland

3. Department of Medical Oncology The Clatterbridge Cancer Centre Wirral UK

4. Department of Cancer Biology The University of Texas–MD Anderson Cancer Center Houston TX USA

5. Department of Cellular and Molecular Physiology University of Liverpool Liverpool UK

6. Liverpool Clinical Laboratories Royal Liverpool University Hospital Liverpool UK

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/path.5384

Reference307 articles.

1. Uveal Melanoma: Epidemiologic Aspects

2. Uveal melanoma: relatively rare but deadly cancer

3. Immunotherapy for the Treatment of Uveal Melanoma: Current Status and Emerging Therapies

4. Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma

5. Tumor Mutational Burden and Response Rate to PD-1 Inhibition

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New immunotherapy approaches as the most effective treatment for uveal melanoma;Critical Reviews in Oncology/Hematology;2024-02

2. Balanced Epigenetic Regulation of MHC Class I Expression in Tumor Cells by the Histone Ubiquitin Modifiers BAP1 and PCGF1;The Journal of Immunology;2023-12-13

3. Characterisation of the protein expression of the emerging immunotherapy targets VISTA, LAG-3 and PRAME in primary uveal melanoma: insights from a southern French patient cohort;Pathology;2023-12

4. Silencing of genes by promoter hypermethylation shapes tumor microenvironment and resistance to immunotherapy in clear-cell renal cell carcinomas;Cell Reports Medicine;2023-11

5. The Interplay Between the Immune System, Tumor Suppressor Genes, and Immune Senescence in Mesothelioma Development and Response to Immunotherapy;Journal of Thoracic Oncology;2023-11